Key facts
- It has raised $120K; the latest was Angel (individual) ($120K) in Dec 2025.
- AI ECD has filed 1 Form D with the SEC, most recently Dec 2025 ($117K sold to 2 investors).
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for AI ECD
- ·The full record, as it builds
Funding rounds
No funding rounds for AI ECD are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About AI ECD
Developer of an agentic AI copilot designed to reduce wait-time bottlenecks, ease clinician workload, lower denials, and receive consistent, high-quality, personalized autism support between visits. The company copilot that records sessions, a personalized plan engine, a measure scheduler, a claim ready note and claim writer with ware cues, and a denials and re authorization guard that auto checks payer policies and supports one click fixes, enabling autism clinics, multidisciplinary therapists and families navigating autism care a secure, clinic grade workflow that accelerates documentation, reduces claim denials, bridges clinic and home routines, and makes personalized autism treatment more accessible and effective.
- Sector
- Healthcare
- HQ
- San Jose, CA, United States
- Founded
- 2024
- Employees
- 2
- Website
- kidooo.ai/
- Ownership
- Privately Held (backing)
AI ECD doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in AI ECD shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on AI ECD in its N-PORT filings yet. We sweep new filings monthly.